WO2001033278A1 - Milieu d'interface pour echantillon de surface tissulaire - Google Patents

Milieu d'interface pour echantillon de surface tissulaire Download PDF

Info

Publication number
WO2001033278A1
WO2001033278A1 PCT/US2000/030306 US0030306W WO0133278A1 WO 2001033278 A1 WO2001033278 A1 WO 2001033278A1 US 0030306 W US0030306 W US 0030306W WO 0133278 A1 WO0133278 A1 WO 0133278A1
Authority
WO
WIPO (PCT)
Prior art keywords
composition
probe
refraction
index
tissue surface
Prior art date
Application number
PCT/US2000/030306
Other languages
English (en)
Inventor
Jenny Freeman
James Mansfield
Andrea Pierce
Pierre Trepagnier
Michael J. Hopmeier
Original Assignee
Argose, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Argose, Inc. filed Critical Argose, Inc.
Priority to JP2001535106A priority Critical patent/JP2003512916A/ja
Priority to CA002389450A priority patent/CA2389450A1/fr
Priority to EP00976876A priority patent/EP1226462A1/fr
Priority to AU14589/01A priority patent/AU1458901A/en
Publication of WO2001033278A1 publication Critical patent/WO2001033278A1/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/0059—Measuring for diagnostic purposes; Identification of persons using light, e.g. diagnosis by transillumination, diascopy, fluorescence
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
    • G01N21/01—Arrangements or apparatus for facilitating the optical investigation
    • G—PHYSICS
    • G02—OPTICS
    • G02B—OPTICAL ELEMENTS, SYSTEMS OR APPARATUS
    • G02B21/00—Microscopes
    • G02B21/33—Immersion oils, or microscope systems or objectives for use with immersion fluids

Definitions

  • This invention relates to compositions useful as interface media for facilitating contact between a surface and a probe and to methods for using these compositions, and, in particular, to interface media for optically coupling, standardizing, and improving contact between a tissue surface, such as skin, and a probe being used to collect fluorescence or another desired spectra from the tissue.
  • spectrofluorometer products are available for taking skin fluorescence spectra (e.g. the Instruments S.A. SkinSkan). These devices are typically used in the cosmetics industry and often involve a fiber optic probe, which is simply pressed against the skin. However, bringing the fiber optic probe into simple direct contact with the skin has various disadvantages.
  • the surface of the skin is not perfectly smooth, but contains small hills and valleys, due, for example, to pores, wrinkles, hair follicles, and other surface irregularities. These irregularities can lead to small air pockets between the probe and the skin surface. Although the fiber optic probe and skin often share similar indices of refraction, both are significantly higher than air. Thus, the presence of air pockets may lead to additional scattering due to index mismatch at the probe/air and air/skin interfaces. These effects can induce higher variation in the spectra than would otherwise be the case, causing unnecessary noise.
  • Glycerol has been used experimentally as an interface medium in acquiring spectra of mucous membranes, specifically for research programs aimed at early detection of cancer of the cervix using fluorescence spectra, see, for example PCT Patent Application No. US99/07565; and U.S. Patent Nos. 5,601,079 and 5,341,805.
  • an interface medium that optimizes optical coupling between a tissue surface, such as skin, and a probe. This optical coupling agent would enhance both the transfer of light from the probe to the tissue, and the collection of light, such as fluorescence spectra, from the tissue to the probe.
  • compositions of the invention may also be used for calibration, such as calibrating the application of pressure between a probe and a surface, standardization such as standardizing the spectral output (e.g. fluorescence, infrared, thermal, or visible) of the instrument, or both, or to alter the metabolism, physiology, chemical, or other state of the tissue or surface.
  • standardization such as standardizing the spectral output (e.g. fluorescence, infrared, thermal, or visible) of the instrument, or both, or to alter the metabolism, physiology, chemical, or other state of the tissue or surface.
  • one embodiment of the invention is directed to a composition for optically coupling a surface to a probe, comprising a viscous material having an index of refraction which approximates both the index of refraction of the surface and the index of refraction of the probe.
  • the index of refraction of the material is approximately 1.4.
  • the material may be a liquid or gel and is preferably clear in the spectral region of 270-500 nm, water soluble, non-toxic, and pH buffered.
  • Another embodiment is directed to an improved method for measuring fluorescence emitted from a tissue surface comprising coupling a probe to the tissue surface using a composition according to the present invention and measuring fluorescence collected by the probe.
  • Another embodiment is directed to a method for optically coupling a surface to a probe comprising applying a composition according to the present invention to either the surface or probe or both, and bringing the surface, probe and composition into contact with each other.
  • Another embodiment is directed to a method for calibrating the pressure applied by a probe to a tissue surface comprising disposing a composition containing a fluorescent or phosphorescent dye between the probe and the tissue surface, applying pressure to the tissue surface with the probe causing at least a portion of the composition between the probe and tissue surface to thin out or disperse, exciting the dye in the composition which remains between the probe and tissue surface, and measuring excitation of the dye.
  • the present invention is directed to the measurement of fluorescence spectra on the skin or other tissue using a novel composition which optimizes coupling of the tissue surface to the probe. More specifically, the present invention relates to compositions useful as an interface media between the fiber optic probe and skin, for the purpose of taking more accurate and repeatable spectra.
  • compositions according to the present invention preferably comprise a viscous material or medium, such as a liquid, paste or gel, having an index of refraction that matches or approximates the indices of both the tissue surface and the probe which may be, for example, a simply quartz fiber (i.e. fused silica) probe.
  • a viscous material or medium such as a liquid, paste or gel
  • the probe which may be, for example, a simply quartz fiber (i.e. fused silica) probe.
  • "Probe” or “optical probe” denote the optical train used to bring light to, and collect light from, the tissue sample.
  • the probe is made up of optical fibers, but it may contain other refractive and reflective optical elements.
  • Tissue surfaces are preferably skin surfaces but may also include the surface of mucus membranes or other surfaces of the body that can be easily contacted with the probe and, preferably, non-invasively contacted.
  • the index of refraction is between 1.1 and 2.0, more preferably between 1.2 and 1.8 and even more preferably 1.4.
  • the medium is preferably clear in the visible spectral region of 400 - 700 nm, more preferably in the region of 270 - 500 nm, and may be pH buffered; non-toxic, for example, not substantially toxic at the concentration being used to the organism on which the composition is being administered; or both.
  • the medium of the present invention allows for improved probe-to-tissue contact, even in the presence of dry skin, scaling skin, or air pockets due to skin texture, or other irregularities such as pits in the nail bed.
  • the medium minimizes subject- to-subject variability, or site-to-site variability on a human subject, based on skin differences such as pigmentation, hair density, thickness, blood flow, and like physiological variables.
  • the medium is preferably slippery, allowing for reduced friction and mechanical stress between the skin and probe. Further, accuracy and reproducibility are enhanced by providing improved thermal contact between the skin and the probe. This thermal buffering stabilizes and increases the thermal stability of the interface.
  • an interface medium may contain one or more pharmaceutical agents that, upon application to the tissue, introduce therapeutically effective amounts of the pharmaceutical to the local environment.
  • An interface medium may contain, for example, an effective amount of a pharmaceutical agent that modifies or stabilize local tissue perfusion or metabolism, or other aspects of the tissue environment. Stabilization or control of the local environment augments and improves data acquisition.
  • the medium is preferably water soluble for ease of application and removal and may be non-staining, but in some applications may be water insoluble.
  • the medium comprise as the principal component an optically inactive ingredient, i.e., substantially inert and substantially transparent to allow the transfer of light with no more than negligible interference, for example, glycerin, polyethylene glycol such as, for example, most any PEG such as PEG-200, PEG-400 or PEG-600, polypropylene glycol, phosphate or combinations of these ingredients, and one or more buffers and/or wetting agents.
  • Additional secondary components include PEG- 150 stearate or distearate, glyceral stearate, cetyl alcohol or combinations thereof. Concentrations for the secondary components range from 0.01% to 20%, preferably 0.1 % to 10%, and more preferably 1% to 5%, and even more preferably 2%.
  • the present invention may be used in a variety of applications, including, but not limited to, human and veterinary medical and dental applications, forensic analysis, and other applications where spectral information is collected with a probe from a surface.
  • An important feature of the present invention is its ability to be modified to serve as a calibrator of the amount of pressure used in measurement.
  • the invention can be used as a standard which can serve as a basis for measuring the internal fluctuation in the components of the instrument, such as the wand.
  • Ingredients that can be used include any optically responsive materials such as, for example, fluorescent, phosphorescent or bioluminescent ingredients, or combinations of such ingredients.
  • the calibration function may be achieved, for example, by the addition of a small amount of optically active material to the medium such as, for example, a fluorescent or phosphorescent dye.
  • optically active ingredients include, for example, fluorescein, acridine orange, 6-diamidino-2-phenylindole (DAPI), Hoechst 33358, cascade yellow, rhodamine and rhodamine derivatives such as rhodamine 6G, tetramethylrhodamine, rhodamine 800, 5-carboxyrhodamine 6G hydrochloride, lissamine rhodamine B sulfonal chloride and Texas Red sulfonyl chloride, azure (e.g.
  • BIODIPY azure B
  • ethidium bromide e.g. thiazole orange
  • nile blue Al phthalocyanine
  • Mag-Indo-1, oxazine BIODIPY and its derivatives such as BIODIDY-FL, BIODIPY-R6G, BIODIPY-TMR, BIODIPY-581/591, BIODIPY-Texas Red, fluorescine (e.g. fura-red fluorescein), and combinations thereof (many of these chemicals are commercially available from Molecular Probes, Inc.).
  • the optically active ingredient is soluble in the primary or secondary component of the medium which, in most cases, would require water solubility, but may require solubility in non-polar materials such as methanol, is insensitive to solvent polarity and pH variations, and is a dye with a useful fluorescence emission spectrum in the range of 450 nm to 750 nm, preferably between 500 and 700 nm, and more preferably between 550 nm and 650 nm.
  • the amount of the spectrally active component in the medium may vary considerably depending on the analytical equipment and the activity of the component itself. Preferred concentrations range from less than 0.0001% to more than 5%, preferably between 0.001% and 2%, and more preferably between 0.01% and 1%.
  • the dye is excited by the spectrofluorometer.
  • the spectrally active component of the medium may be passive or active, and produce a colormetric change or other spectral change that can be easily detected.
  • the active agent is a dye that fluoresces or phosphoresces in a benign (i.e. not relevant) spectral region.
  • its spectral response may be built into the analysis algorithm.
  • Another embodiment is directed to a thermo-regulated medium that can be actively or passively thermo-regulated such as a crystal that breaks down or crystallizes in response to heat or spectral energy. Accordingly, the medium may be used to monitor or determine skin temperature.
  • Another embodiment is directed to a medium of the invention that is sterilized or sterilizable such that it can be used in a sterile environment or when sterile conditions are required.
  • the interface medium may be packaged in a membrane or barrier (which may be bacteria permeable or impermeable) such that the surface to which it is applied does not contact the medium, but the membrane which may itself be sterile.
  • Membranes such as paper; glass; plastic; polymers, such as nylon, Tyvec®, Teflon®; co-polymers of vinyliden chloride and vinyl chloride; and combinations thereof may be used to package the medium for specific applications such as in a glove or sleeve, or for further processing such as conventional sterilization.
  • such membranes or barriers are clear to allow easy visualization and use of the medium without allowing passage of the ingredients through the barrier.
  • the invention may also serve as a standardization tool to standardize instruments used in surface spectral analysis, for example, see PCT Application No. US99/07565. Similar to the calibration modification, a small amount of fluorescent or phosphorescent dye is added to the medium such that the dye is excited by the spectrofluorometer or, alternatively, emits its own wavelength. In this manner, the instrument can be very precisely standardized. Of course, one modified medium or a mixture of mediums can perform both calibration and standardization functions simultaneously.
  • a film of the medium is placed between the probe and skin.
  • Increased probe/skin pressure causes the film to become thinner and hence the dye output to be less.
  • the spectrofluorometer insures optimum skin contact.
  • the film may be applied in a number of ways, for example, by being impregnated into a foam so that it is squeezed out when pressure is applied, or by being otherwise encapsulated near the probe.
  • the intensity of returned light is indicative of the thickness of the film and, thus, the pressure being asserted against the skin.
  • the spectral location, i.e., wavelength, of the peak can be used to calibrate or otherwise standardize the instrument.
  • the present invention also is directed to novel methods of using the compositions of the present invention.
  • One such embodiment is directed to a method for measuring fluorescence emitted from a tissue surface. This method comprises the steps of coupling a probe to the tissue surface using a composition according to the present invention and measuring fluorescence collected by the probe.
  • Another embodiment is directed to a method for optically coupling a surface to a probe comprising applying a composition according to the present invention to the surface or probe or both, and bringing the surface, probe and composition into contact with each other.
  • Another embodiment is directed to a method for reducing variability in the tissue, and particularly skin, by filling in and smoothing out surface irregularities by applying a composition according to the present invention to the surface.
  • Another embodiment is directed to a method for calibrating the pressure applied by a probe to a tissue surface comprising disposing the composition of the present invention between the probe and the tissue surface, applying pressure to the tissue surface with the probe causing at least a portion of the composition between the probe and tissue surface to disperse or thin out, exciting the dye in the composition remaining between the probe and tissue surface, and measuring excitation of the dye.
  • Excitation may be produced by the induced pressure or simply the increased heat of the living surface.
  • the composition may also be used as a standardization tool whereby the instrument or components of the instrument such as the optical cable of the wand are spectrally standardized.

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Chemical & Material Sciences (AREA)
  • Pathology (AREA)
  • Analytical Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Biomedical Technology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biophysics (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Medical Informatics (AREA)
  • Molecular Biology (AREA)
  • Surgery (AREA)
  • Immunology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Optics & Photonics (AREA)
  • Investigating, Analyzing Materials By Fluorescence Or Luminescence (AREA)
  • Measurement Of The Respiration, Hearing Ability, Form, And Blood Characteristics Of Living Organisms (AREA)
  • Cosmetics (AREA)

Abstract

La présente invention concerne une composition pouvant servir de milieu d'interface pour permettre un couplage optique et faciliter le contact entre un échantillon et une surface tissulaire, telle que la peau. Les compositions de la présente invention présentent un indice de réfraction d'environ 1,4, ce qui se rapproche des indices des deux éléments que sont la peau et l'échantillon, et peuvent être claires dans le domaine spectral de 270-500 nm, tamponnées à un pH, glissantes, solubles dans l'eau, et visqueuses. Les compositions peuvent également être utilisées pour calibrer l'application de pression entre un échantillon et une surface et standardiser le fonctionnement de l'instrument, ou pour adapter la surface dans le but d'optimiser l'utilisation de l'instrument.
PCT/US2000/030306 1999-11-03 2000-11-03 Milieu d'interface pour echantillon de surface tissulaire WO2001033278A1 (fr)

Priority Applications (4)

Application Number Priority Date Filing Date Title
JP2001535106A JP2003512916A (ja) 1999-11-03 2000-11-03 組織表面プローブ用の界面媒体
CA002389450A CA2389450A1 (fr) 1999-11-03 2000-11-03 Milieu d'interface pour echantillon de surface tissulaire
EP00976876A EP1226462A1 (fr) 1999-11-03 2000-11-03 Milieu d'interface pour echantillon de surface tissulaire
AU14589/01A AU1458901A (en) 1999-11-03 2000-11-03 Interface medium for tissue surface probe

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US16327499P 1999-11-03 1999-11-03
US60/163,274 1999-11-03

Publications (1)

Publication Number Publication Date
WO2001033278A1 true WO2001033278A1 (fr) 2001-05-10

Family

ID=22589256

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2000/030306 WO2001033278A1 (fr) 1999-11-03 2000-11-03 Milieu d'interface pour echantillon de surface tissulaire

Country Status (5)

Country Link
EP (1) EP1226462A1 (fr)
JP (1) JP2003512916A (fr)
AU (1) AU1458901A (fr)
CA (1) CA2389450A1 (fr)
WO (1) WO2001033278A1 (fr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2620909C2 (ru) * 2012-02-28 2017-05-30 Конинклейке Филипс Н.В. Устройство для лечения кожи, основанного на свете

Citations (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3929667A (en) 1974-06-19 1975-12-30 R P Cargille Lab Inc Immersion oil formulations for use in microscopy and similar fields
US4526711A (en) 1983-09-09 1985-07-02 R. P. Cargille Laboratories, Inc. High refractive index fluid and melt mounting media
US5001353A (en) * 1989-01-17 1991-03-19 Sumitomo Light Metal Industries, Ltd. Method and apparatus to measure the thickness of coating films
US5300097A (en) * 1991-02-13 1994-04-05 Lerner Ethan A Fiber optic psoriasis treatment device
US5341805A (en) 1993-04-06 1994-08-30 Cedars-Sinai Medical Center Glucose fluorescence monitor and method
US5354825A (en) 1985-04-08 1994-10-11 Klainer Stanley M Surface-bound fluorescent polymers and related methods of synthesis and use
US5601079A (en) 1992-03-12 1997-02-11 Wong; Jacob Y. Non-invasive quantification of glucose control, aging, and advanced maillard products by stimulated fluorescence
US5655530A (en) * 1995-08-09 1997-08-12 Rio Grande Medical Technologies, Inc. Method for non-invasive blood analyte measurement with improved optical interface
US5667840A (en) 1996-02-27 1997-09-16 Becton Dickinson And Company Lubricant soluble fluorescent agent and method for its use in a system for detection of lubricant coatings
WO1999051142A2 (fr) * 1998-04-06 1999-10-14 The General Hospital Corporation Suivi non invasif du taux de glucose tissulaire
WO1999051148A2 (fr) 1998-04-08 1999-10-14 Shturman Cardiology Systems, Inc. Dispositif rotatif d'atherectomie muni d'un tachymetre optique ameliore

Patent Citations (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3929667A (en) 1974-06-19 1975-12-30 R P Cargille Lab Inc Immersion oil formulations for use in microscopy and similar fields
US4526711A (en) 1983-09-09 1985-07-02 R. P. Cargille Laboratories, Inc. High refractive index fluid and melt mounting media
US5354825A (en) 1985-04-08 1994-10-11 Klainer Stanley M Surface-bound fluorescent polymers and related methods of synthesis and use
US5480723A (en) 1985-04-08 1996-01-02 Optical Sensors Incorporated Surface-bound fluorescent polymers and related methods of synthesis and use
US5001353A (en) * 1989-01-17 1991-03-19 Sumitomo Light Metal Industries, Ltd. Method and apparatus to measure the thickness of coating films
US5300097A (en) * 1991-02-13 1994-04-05 Lerner Ethan A Fiber optic psoriasis treatment device
US5601079A (en) 1992-03-12 1997-02-11 Wong; Jacob Y. Non-invasive quantification of glucose control, aging, and advanced maillard products by stimulated fluorescence
US5341805A (en) 1993-04-06 1994-08-30 Cedars-Sinai Medical Center Glucose fluorescence monitor and method
US5655530A (en) * 1995-08-09 1997-08-12 Rio Grande Medical Technologies, Inc. Method for non-invasive blood analyte measurement with improved optical interface
US5667840A (en) 1996-02-27 1997-09-16 Becton Dickinson And Company Lubricant soluble fluorescent agent and method for its use in a system for detection of lubricant coatings
WO1999051142A2 (fr) * 1998-04-06 1999-10-14 The General Hospital Corporation Suivi non invasif du taux de glucose tissulaire
WO1999051148A2 (fr) 1998-04-08 1999-10-14 Shturman Cardiology Systems, Inc. Dispositif rotatif d'atherectomie muni d'un tachymetre optique ameliore

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2620909C2 (ru) * 2012-02-28 2017-05-30 Конинклейке Филипс Н.В. Устройство для лечения кожи, основанного на свете
US9884202B2 (en) 2012-02-28 2018-02-06 Koninklijke Philips N.V. Device for light based skin treatment
US20180140868A1 (en) * 2012-02-28 2018-05-24 Koninklijke Philips N.V. Device for light based skin treatment
US20180154173A1 (en) * 2012-02-28 2018-06-07 Koninklijke Philips N.V. Device for light based skin treatment
US10434326B2 (en) 2012-02-28 2019-10-08 Koninklijke Philips N.V. Device for light based skin treatment
US10471275B2 (en) 2012-02-28 2019-11-12 Koninklijke Philips N.V. Device for light based skin treatment
US11007377B2 (en) 2012-02-28 2021-05-18 Koninklijke Philips N.V. Device for light based skin treatment

Also Published As

Publication number Publication date
CA2389450A1 (fr) 2001-05-10
JP2003512916A (ja) 2003-04-08
AU1458901A (en) 2001-05-14
EP1226462A1 (fr) 2002-07-31

Similar Documents

Publication Publication Date Title
Pape et al. An audit of the use of laser Doppler imaging (LDI) in the assessment of burns of intermediate depth
US8718738B2 (en) Method and apparatus for coupling a sample probe with a sample site
JP3679800B2 (ja) グルコース蛍光検査方法
Milner et al. Depth determination of chromophores in human skin by pulsed photothermal radiometry
Colston et al. Dental oct
US6654620B2 (en) Method for improving non-invasive determination of the concentration of analytes in a biological sample
EP2569607B1 (fr) Embout à main à système optique intégré pour mesures de radiométrie photothermique et de luminescence
Jones et al. Attenuation of 1310-and 1550-nm laser light through sound dental enamel
WO2000053101A1 (fr) Dispositifs pour marquer la peau et leur utilisation
McShane et al. Monte Carlo modeling for implantable fluorescent analyte sensors
Hirasuna et al. Near-infrared imaging of developmental defects in dental enamel
CA2089709A1 (fr) Element capteur et methode de fabrication connexe
US5094248A (en) Device and method for simple visual measurement of the amount of sebum present on human skin
EP0253492A2 (fr) Sonde à fibre optique
Li et al. Refractive index of human whole blood with different types in the visible and near-infrared ranges
JP2007083028A (ja) 非侵襲性検査装置
Kermanshah et al. Comparison of microleakage of Scotchbond™ Universal Adhesive with methacrylate resin in Class V restorations by two methods: Swept source optical coherence tomography and dye penetration
Lübbers Optical sensors for clinical monitoring
Doukas et al. Fluorescence Excitation Spectroscopy for the Measurement of Epidermal Proliferation¶
Martin et al. Fibre-optics and optical sensors in medicine
WO2001033278A1 (fr) Milieu d'interface pour echantillon de surface tissulaire
LaMantia et al. High contrast optical imaging methods for image guided laser ablation of dental caries lesions
Lee et al. Tools of dermatology: A historical perspective
Zeimer et al. Evaluation of an objective method for the in vivo measurement of changes in light transmittance of the human crystalline lens
Nilsen et al. Comparison between reflectance spectra obtained with an integrating sphere and a fiber optic collection system

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
WWE Wipo information: entry into national phase

Ref document number: 2389450

Country of ref document: CA

WWE Wipo information: entry into national phase

Ref document number: 14589/01

Country of ref document: AU

ENP Entry into the national phase

Ref country code: JP

Ref document number: 2001 535106

Kind code of ref document: A

Format of ref document f/p: F

WWE Wipo information: entry into national phase

Ref document number: 2000976876

Country of ref document: EP

WWP Wipo information: published in national office

Ref document number: 2000976876

Country of ref document: EP

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

WWW Wipo information: withdrawn in national office

Ref document number: 2000976876

Country of ref document: EP